< Previous page
All
Airlines/Aviation
Auto
Maritime/Shipbuilding
Transportation
Computer Hardware
Computer Networks
Computer Software
Computer/Electronics
Electronic Commerce
Electronic Components
High Tech Security
Internet Technology
Peripherals
Semiconductors
Electronics Gaming
Consumer Electronics
Mobile Entertainment
Multimedia/Online/Internet
Telecommunications
Household/Consumer/Cosmetics
Retail
Supermarkets
Toys
Alternative Energies
Chemical
Mining/Metals
Oil/Energy
Environmental Products & Services
Green Technology
Art
Cosmetics & Personal Care
Entertainment
Fashion
Film & Motion Picture
Jewelry
Banking/Financial Service
Insurance
Workforce Management/Human Resources
Education
Higher Education
Biotechnology
Health Care/Hospital
Infectious Disease Control
Medical Equipment
Medical/Pharmaceuticals
Agriculture
Machinery
Paper/Forest Products/Containers
Textiles
Domestic policy
Legal issues
Sports
Hotels and Resorts
Leisure/Travel/Hotels
Travel
Restaurants
Beer, Wine & Spirits
Beverages
Non-Alcoholic Beverages
Food/Beverages
Advertising
Books
Music
Publishing/Information Service
Television
Trade show news
Real Estate
Construction/Building
Furniture & Furnishings
|
Title only
|
Print
Next page >
88IV - PR Newswire Asia's news - Medical/Pharmaceuticals
5
HMI Medical Strengthens Diagnostic Capabilities to Support Singapore's Shift Beyond Hospital Care
With the addition of Lifescan Imaging, HMI Medical now operates a network of seven diagnostic and imaging centres, enhancing access to timely diagnosis while supporting coordinated patient care across ...
2026-08-13T
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
SHANGHAI , Aug. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the Investigational New Drug (IND) application for AK0406 injection, the company's ...
2026-08-13T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN® at Aesthetics 2026
Following REJURAN ® 's TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals. ...
2026-08-13T
Biotechnology
Cosmetics & Personal Care
Medical Equipment
Medical/Pharmaceuticals
VITAMIN ANGELS EXPANDS PARTNERSHIP WITH THE MINISTRY OF HEALTH OF INDONESIA TO STRENGTHEN NATIONWIDE VITAMIN A CAMPAIGN
Collaboration strengthened health worker training, communication strategies, monitoring and evaluation, and delivered 870,000 vitamin A capsules for children across Indonesia. ...
2026-08-13T
Education
Health Care/Hospital
Medical/Pharmaceuticals
Osara Health Marks 10 Years with Global Call to Make Cancer Support Beyond Treatment Standard
Launched to mark the company's 10th anniversary, Osara Health's Global Cancer Support Declaration has already secured signatures from healthcare professionals worldwide. ...
2026-08-12T
Computer/Electronics
Health Care/Hospital
Medical/Pharmaceuticals
PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
NANJING, China , Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO ® ...
2026-08-12T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
CAMBRIDGE, Mass. , Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company , today ...
2026-08-12T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing
Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ...
2026-08-12T
Biotechnology
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
Beyang Closes Oversubscribed $30 Million Series A Financing
Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor ...
2026-08-12T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Senhwa's CX-5461 Opens a New Frontier in Photoimmunotherapy; Multinational Study Published in Nucleic Acids Research
TAIPEI and SAN DIEGO , Aug. 12, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. ( TPEx : 6492) today announced a significant research advance involving its investigational drug Pidnarulex (CX-5461). ...
2026-08-12T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
< Previous page
Next page >
Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.